T cell immune abnormalities in immune thrombocytopenia

被引:66
作者
Ji, Xuebin [1 ]
Zhang, Liping [2 ]
Peng, Jun [1 ]
Hou, Ming [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250012, Shandong, Peoples R China
[2] Jinan Stomatol Hosp, Jinan, Peoples R China
关键词
Immune thrombocytopenia; T cell; Immune tolerance; Pathogenesis; INTERLEUKIN-18; BINDING-PROTEIN; HIGH-DOSE DEXAMETHASONE; DENDRITIC CELLS; CTL RESPONSES; LIGAND TRAIL; IN-VITRO; ICOS; APOPTOSIS; ACTIVATION; IMMUNOGLOBULIN;
D O I
10.1186/s13045-014-0072-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immune thrombocytopenia is an autoimmune disease with abnormal T cell immunity. Cytotoxic T cells, abnormal T regulatory cells, helper T cell imbalance, megakaryocyte maturation abnormalities and abnormal T cell anergy are involved in the pathogenesis of this condition. The loss of T cell-mediated immune tolerance to platelet auto-antigens plays a crucial role in immune thrombocytopenia. The induction of T cell tolerance is an important mechanism by which the pathogenesis and treatment of immune thrombocytopenia can be studied. Studies regarding the roles of the new inducible costimulator signal transduction pathway, the ubiquitin proteasome pathway, and the nuclear factor kappa B signal transduction pathway in the induction of T cell tolerance can help improve our understanding of immune theory and may provide a new theoretical basis for studying the pathogenesis and treatment of immune thrombocytopenia.
引用
收藏
页数:6
相关论文
共 58 条
[1]   Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells [J].
Abrams, JR ;
Kelley, SL ;
Hayes, E ;
Kikuchi, T ;
Brown, MJ ;
Kang, SW ;
Lebwohl, MG ;
Guzzo, CA ;
Jegasothy, BV ;
Linsley, PS ;
Krueger, JG .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (05) :681-693
[2]   Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia [J].
Aslam, Rukhsana ;
Hu, Yu ;
Gebremeskel, Simon ;
Segel, George B. ;
Speck, Edwin R. ;
Guo, Li ;
Kim, Michael ;
Ni, Heyu ;
Freedman, John ;
Semple, John W. .
BLOOD, 2012, 120 (10) :2127-2132
[3]   Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment [J].
Bathe, OF ;
Dalyot-Herman, N ;
Malek, TR .
BMC CANCER, 2003, 3 (1)
[4]   The serum levels of the cytokines involved in the Th17 and Th1 cell commitment are increased in individuals with borderline thrombocytopenia [J].
Camargos Rocha, Andreia Maria ;
Souza, Claudia ;
Rocha, Gifone Aguiar ;
de Melo, Fabricio Freire ;
Diogo Clementino, Nelma Cristina ;
Abreu Marino, Marilia Campos ;
Magalhaes Queiroz, Dulciene Maria .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
[5]   Regulation of NF-κB induction by TCR/CD28 [J].
Cheng, Jing ;
Montecalvo, Angela ;
Kane, Lawrence P. .
IMMUNOLOGIC RESEARCH, 2011, 50 (2-3) :113-117
[6]   The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131 [J].
Choi, Yun ;
Lee, Ho Won ;
Lee, Jaetae ;
Jeon, Yong Hyun .
BMC CANCER, 2013, 13
[7]   The CD28-related molecule ICOS is required for effective T cell-dependent immune responses [J].
Coyle, AJ ;
Lehar, S ;
Lloyd, C ;
Tian, J ;
Delaney, T ;
Manning, S ;
Nguyen, T ;
Burwell, T ;
Schneider, H ;
Gonzalo, JA ;
Gosselin, M ;
Owen, LR ;
Rudd, CE ;
Gutierrez-Ramos, JC .
IMMUNITY, 2000, 13 (01) :95-105
[8]   Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets [J].
Crist, SA ;
Elzey, BD ;
Ludwig, AT ;
Griffith, TS ;
Staack, JB ;
Lentz, SR ;
Ratliff, TL .
EXPERIMENTAL HEMATOLOGY, 2004, 32 (11) :1073-1081
[9]   ICOS co-stimulatory receptor is essential for T-cell activation and function [J].
Dong, C ;
Juedes, AE ;
Temann, UA ;
Shresta, S ;
Allison, JP ;
Ruddle, NH ;
Flavell, RA .
NATURE, 2001, 409 (6816) :97-101
[10]   AUTOREACTIVE T-CELLS IN HEALTHY-INDIVIDUALS SHOW TOLERANCE IN-VITRO WITH CHARACTERISTICS SIMILAR TO BUT DISTINCT FROM CLONAL ANERGY [J].
FILION, MC ;
BRADLEY, AJ ;
DEVINE, DV ;
DECARY, F ;
CHARTRAND, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) :3123-3127